Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Novo's semaglutide among 2nd batch of drugs selected for IRA price negotiations
The U.S. government has selected the second batch of drugs up for Medicare price negotiations under the Inflation Reduction Act. | The U.S. government has selected the second batch of drugs up for Medicare price negotiations under the Inflation Reduction Act.
Medicare announces plan to negotiate prices of diabetes, weight loss drugs
WASHINGTON — Medicare officials announced plans to negotiate the prices of blockbuster diabetes and weight loss drugs Ozempic and Wegovy, further complicating big decisions the Trump administration will have to make about how to cover the medications.
Popular Ozempic, Wegovy Selected For Next Round Of Medicare Drug Price Negotiations
On Friday, the U.S. Department of Health and Human Services (HHS) unveiled the selection of 15 additional drugs covered under Medicare Part D for price negotiations, building on efforts to reduce prescription drug costs.
Medicare targets popular weight loss drugs Ozempic, Wegovy for price negotiations
The Biden administration said Medicare will negotiate discounts with drug companies on 15 drugs prescribed to treat cancer, diabetes and asthma.
Medicare targets 15 more drugs for price negotiations — including Ozempic
On its last weekday in power, the Biden Administration has chosen the next batch of drugs up for price negotiation in Medicare.
pharmaphorum
7d
Amylin Pharmaceuticals bought by Bristol-Myers, expanding diabetes alliance with AstraZeneca
Bristol-Myers Squibb and
AstraZeneca
first joined forces to enable the companies to work together in order to research, develop and commercialise select investigational
drugs
for type 2
diabetes
...
14d
Better Buy: Novo Nordisk vs. AstraZeneca
Novo Nordisk (NYSE: NVO) and AstraZeneca (NASDAQ: AZN) are among the largest companies in the pharmaceutical industry. Both ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Los Angeles wildfire updates
California fires: How to help
To skip Trump’s inauguration
Cabinet approves Gaza deal
Court declares DACA illegal
Rapper charged with assault
US drops corruption case
Thousands protest in Wash.
Fed exits climate group
Ex-CIA analyst pleads guilty
Resentencing date pushed
DOJ sues Walgreens
Suspends US drone deliveries
Senate confirmation hearing
Liable for defaming veteran
New Pompeii excavation
NHTSA probing GM vehicles
Former utility execs indicted
FTC sues PepsiCo
Vanguard fined by SEC
Polar vortex to freeze US
Ovechkin breaks NHL record
CA battery storage plant fire
To negotiate drug prices
Sasaki signs with Dodgers
Commutes more sentences
Navalny lawyers sentenced
Denied bail in assault case
Judge denies bail ruling
Advance to AFC title game
Feedback